back to cluster viewer
cluster path 0011111001111100
82 words, 12,062 tokens
freq alpha suffix
Words in frequency order
1 | comorbidities | 2,699
|
2 | side-effects | 2,618
|
3 | toxicities | 2,070
|
4 | comorbidity | 1,913
|
5 | disabilities | 901
|
6 | co-morbidities | 663
|
7 | co-morbidity | 429
|
8 | exclusions | 238
|
9 | re-operations | 54
|
10 | handicaps | 53
|
11 | assaults | 42
|
12 | after-effects | 40
|
13 | cointerventions | 28
|
14 | methanogens | 26
|
15 | saccharides | 21
|
16 | consumables | 20
|
17 | psychopathologies | 17
|
18 | nephrons | 15
|
19 | misdiagnoses | 13
|
20 | toxicoses | 13
|
21 | decentralization | 12
|
22 | hematotoxicity | 11
|
23 | nocardiosis | 9
|
24 | polioviruses | 9
|
25 | capillarity | 7
|
26 | methanosarcinales | 7
|
27 | mononeuropathy | 7
|
28 | ankyloglossia | 6
|
29 | parasuicides | 5
|
30 | thermochemolysis | 5
|
31 | atheroemboli | 4
|
32 | bronchiectases | 4
|
33 | gigahertz | 4
|
34 | manufacturability | 4
|
35 | sepsis/shock | 4
|
36 | telecanthus | 4
|
37 | al-6598 | 3
|
38 | burials | 3
|
39 | chromosomopathies | 3
|
40 | drug-drug-interactions | 3
|
41 | drug-interactions | 3
|
42 | ipss-q8 | 3
|
43 | meta-awareness | 3
|
44 | reoccurrences | 3
|
45 | streptomycetes | 3
|
46 | subfactors | 3
|
47 | vernix | 3
|
48 | 16years | 2
|
49 | 8-hydroxyguanine | 2
|
50 | aberrances | 2
|
51 | akts | 2
|
52 | comorbilities | 2
|
53 | d17s1327 | 2
|
54 | desertion | 2
|
55 | dysfibrinogenemia | 2
|
56 | map-iop | 2
|
57 | mood/fatigue | 2
|
58 | n-acylethanolamines | 2
|
59 | p202/3wt | 2
|
60 | qol-domains | 2
|
61 | quetiapine- | 2
|
62 | sd-scores | 2
|
63 | symtpoms | 2
|
64 | toxicites | 2
|
65 | vanilloids | 2
|
66 | vesicants | 2
|
67 | 3'-nucleotidases | 1
|
68 | audio-sonometric | 1
|
69 | bacturia | 1
|
70 | bronchospasma | 1
|
71 | capsaicin-receptor | 1
|
72 | disorders/ailments | 1
|
73 | fieldnotes | 1
|
74 | genes-spvr | 1
|
75 | immatures | 1
|
76 | myelopathy/radiculopathy | 1
|
77 | progestatif | 1
|
78 | recognition.results | 1
|
79 | retraumatization | 1
|
80 | strongyloidosis | 1
|
81 | targeted-agents | 1
|
82 | taxane-agents | 1
|
Words in alphabetical order
1 | 16years | 2
|
2 | 3'-nucleotidases | 1
|
3 | 8-hydroxyguanine | 2
|
4 | aberrances | 2
|
5 | after-effects | 40
|
6 | akts | 2
|
7 | al-6598 | 3
|
8 | ankyloglossia | 6
|
9 | assaults | 42
|
10 | atheroemboli | 4
|
11 | audio-sonometric | 1
|
12 | bacturia | 1
|
13 | bronchiectases | 4
|
14 | bronchospasma | 1
|
15 | burials | 3
|
16 | capillarity | 7
|
17 | capsaicin-receptor | 1
|
18 | chromosomopathies | 3
|
19 | co-morbidities | 663
|
20 | co-morbidity | 429
|
21 | cointerventions | 28
|
22 | comorbidities | 2,699
|
23 | comorbidity | 1,913
|
24 | comorbilities | 2
|
25 | consumables | 20
|
26 | d17s1327 | 2
|
27 | decentralization | 12
|
28 | desertion | 2
|
29 | disabilities | 901
|
30 | disorders/ailments | 1
|
31 | drug-drug-interactions | 3
|
32 | drug-interactions | 3
|
33 | dysfibrinogenemia | 2
|
34 | exclusions | 238
|
35 | fieldnotes | 1
|
36 | genes-spvr | 1
|
37 | gigahertz | 4
|
38 | handicaps | 53
|
39 | hematotoxicity | 11
|
40 | immatures | 1
|
41 | ipss-q8 | 3
|
42 | manufacturability | 4
|
43 | map-iop | 2
|
44 | meta-awareness | 3
|
45 | methanogens | 26
|
46 | methanosarcinales | 7
|
47 | misdiagnoses | 13
|
48 | mononeuropathy | 7
|
49 | mood/fatigue | 2
|
50 | myelopathy/radiculopathy | 1
|
51 | n-acylethanolamines | 2
|
52 | nephrons | 15
|
53 | nocardiosis | 9
|
54 | p202/3wt | 2
|
55 | parasuicides | 5
|
56 | polioviruses | 9
|
57 | progestatif | 1
|
58 | psychopathologies | 17
|
59 | qol-domains | 2
|
60 | quetiapine- | 2
|
61 | re-operations | 54
|
62 | recognition.results | 1
|
63 | reoccurrences | 3
|
64 | retraumatization | 1
|
65 | saccharides | 21
|
66 | sd-scores | 2
|
67 | sepsis/shock | 4
|
68 | side-effects | 2,618
|
69 | streptomycetes | 3
|
70 | strongyloidosis | 1
|
71 | subfactors | 3
|
72 | symtpoms | 2
|
73 | targeted-agents | 1
|
74 | taxane-agents | 1
|
75 | telecanthus | 4
|
76 | thermochemolysis | 5
|
77 | toxicites | 2
|
78 | toxicities | 2,070
|
79 | toxicoses | 13
|
80 | vanilloids | 2
|
81 | vernix | 3
|
82 | vesicants | 2
|
Words in suffix order
1 | quetiapine- | 2
|
2 | d17s1327 | 2
|
3 | al-6598 | 3
|
4 | ipss-q8 | 3
|
5 | dysfibrinogenemia | 2
|
6 | bacturia | 1
|
7 | ankyloglossia | 6
|
8 | bronchospasma | 1
|
9 | audio-sonometric | 1
|
10 | 8-hydroxyguanine | 2
|
11 | mood/fatigue | 2
|
12 | progestatif | 1
|
13 | atheroemboli | 4
|
14 | sepsis/shock | 4
|
15 | decentralization | 12
|
16 | retraumatization | 1
|
17 | desertion | 2
|
18 | map-iop | 2
|
19 | capsaicin-receptor | 1
|
20 | genes-spvr | 1
|
21 | vanilloids | 2
|
22 | aberrances | 2
|
23 | reoccurrences | 3
|
24 | parasuicides | 5
|
25 | saccharides | 21
|
26 | psychopathologies | 17
|
27 | chromosomopathies | 3
|
28 | toxicities | 2,070
|
29 | co-morbidities | 663
|
30 | comorbidities | 2,699
|
31 | disabilities | 901
|
32 | comorbilities | 2
|
33 | methanosarcinales | 7
|
34 | consumables | 20
|
35 | n-acylethanolamines | 2
|
36 | sd-scores | 2
|
37 | immatures | 1
|
38 | 3'-nucleotidases | 1
|
39 | bronchiectases | 4
|
40 | toxicoses | 13
|
41 | misdiagnoses | 13
|
42 | polioviruses | 9
|
43 | streptomycetes | 3
|
44 | toxicites | 2
|
45 | fieldnotes | 1
|
46 | strongyloidosis | 1
|
47 | nocardiosis | 9
|
48 | thermochemolysis | 5
|
49 | burials | 3
|
50 | symtpoms | 2
|
51 | methanogens | 26
|
52 | qol-domains | 2
|
53 | exclusions | 238
|
54 | re-operations | 54
|
55 | drug-interactions | 3
|
56 | drug-drug-interactions | 3
|
57 | cointerventions | 28
|
58 | nephrons | 15
|
59 | handicaps | 53
|
60 | 16years | 2
|
61 | subfactors | 3
|
62 | meta-awareness | 3
|
63 | side-effects | 2,618
|
64 | after-effects | 40
|
65 | akts | 2
|
66 | assaults | 42
|
67 | recognition.results | 1
|
68 | vesicants | 2
|
69 | targeted-agents | 1
|
70 | taxane-agents | 1
|
71 | disorders/ailments | 1
|
72 | telecanthus | 4
|
73 | p202/3wt | 2
|
74 | vernix | 3
|
75 | myelopathy/radiculopathy | 1
|
76 | mononeuropathy | 7
|
77 | hematotoxicity | 11
|
78 | co-morbidity | 429
|
79 | comorbidity | 1,913
|
80 | manufacturability | 4
|
81 | capillarity | 7
|
82 | gigahertz | 4
|